نتایج جستجو برای: chemoresistance chemotherapy

تعداد نتایج: 117854  

2016
Shuhei Komatsu Daisuke Ichikawa Tsutomu Kawaguchi Hiroki Takeshita Mahito Miyamae Takuma Ohashi Wataru Okajima Taisuke Imamura Jun Kiuchi Tomohiro Arita Hirotaka Konishi Atsushi Shiozaki Hitoshi Fujiwara Kazuma Okamoto Eigo Otsuji

BACKGROUND This study aims to explore novel microRNAs in plasma for predicting chemoresistance in preoperative chemotherapy of patients with esophageal squamous cell carcinoma (ESCC) using a microRNA array-based approach. RESULTS (1) Four candidate microRNAs (miR-223, 103a, 23b and 23a), which were highly expressed in the pretreatment plasma of patients with a low histopathologic response, we...

2013
Alvaro Blanch Fiona Robinson Ian R. Watson Lynn S. Cheng Meredith S. Irwin

The p53 family of transcription factors is a key regulator of cell proliferation and death. In this report we identify the eukaryotic translation elongation factor 1-alpha 1 (eEF1A1) to be a novel p53 and p73 interacting protein. Previous studies have demonstrated that eEF1A1 has translation-independent roles in cancer. We report that overexpression of eEF1A1 specifically inhibits p53-, p73- an...

Journal: :Anticancer research 2012
Shuichi Fujioka Kyonsu Son Shinji Onda Christian Schmidt Guido M Scrabas Tomoyoshi Okamoto Tetsuji Fujita Paul J Chiao Katsuhiko Yanaga

BACKGROUND Chemotherapy-induced nuclear factor kappaB (NFκB) activation is thought to play a key role in acquisition of chemoresistance by cancer cells. We focused on blockade of this activation by using the observation so-called 'desensitization' of NFκB using known NFκB activator, doxycycline. MATERIALS AND METHODS The human pancreatic cancer cell line PANC-1 was incubated with doxycycline,...

2014
LINDA SOOMAN Beatrice Melin

Sooman, L. 2014. Prognostic Biomarkers and Target Proteins for Treatment of High-grade Gliomas. Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 965. 74 pp. Uppsala: Acta Universitatis Upsaliensis. ISBN 978-91-554-8839-0. The survival for high-grade glioma patients is poor and the treatment may cause severe side effects. A common obstacle in the treatment is...

Journal: :International journal of oncology 2010
Catharine A Street Alissa A Routhier Carrie Spencer Ashley L Perkins Katherine Masterjohn Alexander Hackathorn John Montalvo Emily A Dennstedt Brad A Bryan

The role of the RhoA/Rho kinase (ROCK) signaling pathway in cell survival remains a very controversial issue, with its activation being pro-apoptotic in many cell types and anti-apoptotic in others. To test if ROCK inhibition contributes to tumor cell survival or death following chemotherapy, we treated cisplatin damaged neuroblastoma cells with a pharmacological ROCK inhibitor (Y27632) or sham...

Objective(s): Chemoresistance remains the main causes of treatment failure and mortality in cancer patients. There is an urgent need to investigate novel approaches to improve current therapeutic modalities and increase cancer patients' survival. Induction of drug efflux due to overexpression of                  P-glycoproteins is considered as an important leading cause of multidrug resistance...

2014
Jinhua Zhou Yunfei Wang You Wang Xia Yin Yifeng He Lilan Chen Wenwen Wang Ting Liu Wen Di

Cisplatin is commonly used in ovarian cancer chemotherapy, however, chemoresistance to cisplatin remains a great clinical challenge. Oncogenic transcriptional factor FOXM1 has been reported to be overexpressed in ovarian cancer. In this study, we aimed to investigate the potential role of FOXM1 in ovarian cancers with chemoresistance to cisplatin. Our results indicate that FOXM1 is upregulated ...

2016
Jun Huang Ke Liu Deye Song Muliang Ding Junjie Wang Qingping Jin Jiangdong Ni

Osteosarcoma is the most common primary malignant bone tumor, and the frequent acquisition of chemoresistance is often an obstacle to achieving favorable outcomes during chemotherapy. Recently, Krüppel-like factor 4 (KLF4) has been shown to be associated with chemotherapy resistance in a few tumors; however, the involvement of KLF4 in chemotherapy resistance in osteosarcoma cells remains unknow...

Journal: :Cell 2016
Weimin Wang Ilona Kryczek Lubomír Dostál Heng Lin Lijun Tan Lili Zhao Fujia Lu Shuang Wei Tomasz Maj Dongjun Peng Gong He Linda Vatan Wojciech Szeliga Rork Kuick Jan Kotarski Rafał Tarkowski Yali Dou Ramandeep Rattan Adnan Munkarah J. Rebecca Liu Weiping Zou

Effector T cells and fibroblasts are major components in the tumor microenvironment. The means through which these cellular interactions affect chemoresistance is unclear. Here, we show that fibroblasts diminish nuclear accumulation of platinum in ovarian cancer cells, resulting in resistance to platinum-based chemotherapy. We demonstrate that glutathione and cysteine released by fibroblasts co...

2013
XIAOFENG HAN FANGFANG DU LI JIANG YIFEI ZHU ZHEN CHEN YANJUN LIU TINGTING HONG TENG WANG YONG MAO XIAOHONG WU IAIN C. BRUCE JIAN JIN XIN MA DONG HUA

The use of chemotherapy to treat cancer is effective, but chemoresistance reduces this efficacy. Chemotherapy resistance involves several mechanisms, including the cancer stem cell (CSC) concept. The aim of the present study was to assess whether paclitaxel-resistant epithelial ovarian carcinoma is capable of generating cells with CSC-like properties. Using the paclitaxel-resistant A2780/PTX ce...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید